Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Undeniably popular Historical centers: Where Craftsmanship and History Meet - 2A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
- 3Exposure to neighborhood violence leads some Denver teens to use tobacco and alcohol earlier, new study shows
- 44 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- 5How to disinfect if the stomach bug hits your home
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
- Defeating An inability to embrace success in Scholarly world: Individual Victories
- Vote in favor of your #1 Sort of Convenience for a Family
- DEA seizes 1.7 million counterfeit fentanyl pills in Colorado storage unit
- Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
- The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
